Novel bilayer cell patch combining epidermal stem cells and angiogenic adipose stem cells for diabetic wound healing

Teng Ma,Ye Zhao,Guozheng Shen,Bangda Chai,Wei Wang,Xiaoting Li,Zhiwei Zhang,Qingyou Meng
DOI: https://doi.org/10.1016/j.jconrel.2023.06.010
IF: 11.467
2023-07-01
Journal of Controlled Release
Abstract:Diabetic foot ulcer (DFU) is one of the most severe complications in patients with diabetes. However, the development of a promising therapeutic strategy for DFU is still challenging. In this article, we demonstrate a novel bilayer cell patch, and its therapeutic effects on diabetic wound healing have been systematically investigated. The experimental results revealed that diabetes mellitus exosomes (DM-Exos) could inhibit wound healing in normal C57/B6 mice. We identified three microRNAs (miRs) including miR-15a, miR-16, and miR-214 as anti-angiogenesis factors in DM-Exos. Furthermore, angiogenic-modified adipose stem cells (ADSCs, transfected with antagomiR-15a, antagomiR-16, and antagomiR-214) were found to enhance the angiogenesis ability of human umbilical vein endothelial cells (HUVECs) by co-culture. In addition, our findings exhibited that the bilayer cell patch combining epidermal stem cells (EpSCs) and angiogenic-modified ADSCs transplantation could promote diabetic wound healing through enhancing angiogenesis and re-epithelization. These findings illustrate that the novel bilayer cell patch has great potential in diabetic wound healing.
pharmacology & pharmacy,chemistry, multidisciplinary
What problem does this paper attempt to address?